The global infusion devices market is expected to grow at a CAGR of 6.2% in the first half of the forecast period. In 2016, the insulin pumps submarket held the 31% of the global infusion devices market.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 231-page report you will receive 83 tables and 65 figures – all unavailable elsewhere.
The 231-page report provides clear detailed insight into the global infusion devices market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand new report today you stay better informed and ready to act.
Report Scope
• Global Medical Infusion Devices market forecasts to 2027
• This report also breaks down the revenue forecast for global infusion devices market by these submarkets:
– Insulin pumps,
– Enteral feeding pumps
– Other pumps (a grouped category inclusive of chemotherapy pumps and PCA infusion pumps)
This report analyses and dicusses the drivers and restraints for each submarket.
• Our work also shows individual revenue forecasts to 2027 for 12 national markets:
– United States (US)
– Japan
– EU leaders – Germany, France, the UK, Italy and Spain (EU5)
– BRIC nations – Brazil, Russia, India and China.
– South Korea
– RoW
• Our work also shows individual revenue forecasts to 2027 for the Global Drug Delivery Technology market, broken down by these submarkets:
– Oral drug delivery
– Inhalation drug delivery
– Injectable/implantable drug delivery
– Transdermal drug delivery
– Ocular drug delivery
– Nasal drug delivery
• This report discusses the leading products in the global infusion devices market, from several leading companies, including:
– ALCOR Scientific
– Altea Therapeutics
– Animas Corporation
– B.Braun
– Baxter
– CareFusion
– Cellnovo
– Covidien
– D. Medical Industries
– Danone Nutricia
– Debiotech
– Disetronic (Roche)
– Fresenius Kabi
– Hospira
– Insulet Corporation
– Johnson & Johnson
– Medline
– MedSolve Technologies
– Medtronic
– Q Core Medical
– Roche
– Smiths Medical
– SOOIL
– Tandem Diabetes Care
– Valeritas
– Zevex
• This report provides a SWOT analysis of the major strengths and weaknesses of the market, together with the opportunities available and the key threats faced. Moreover, this report proves Porter’s Five Forces Analysis of the global infusion devices market.
Visiongain’s study is for everybody needing commercial analyses for the Infusion Pumps market and leading companies. You will find data, trends and predictions. Please order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
1. Report Overview
1.1 World Infusion Pumps Market Segmentation
1.2 Why You Should Read This Report
1.3 How This Report Delivers: Chapter Outline
1.4 Key Questions Answered by This Analytical Report
1.5 Who is This Report For?
1.6 Methodology
1.7 Frequently Asked Questions (FAQ)
1.8 Associated Visiongain Reports
1.9 About Visiongain
2. Introduction to Infusion Pumps
2.1 Types of Infusion
2.2 Types of Pumps
2.2.1 Gravity Controlled Infusion
2.2.2 Positive Displacement Pumps
2.2.3 Drip Rate Pumps
2.2.4 Volumetric Pumps
2.2.5 Syringe Pumps
2.2.6 Multi-Channel Pumps
2.2.7 Ambulatory Pumps
2.3 History of Infusion Pumps
2.4 What Clinical Settings Will Infusion Pumps Be Useful For?
2.4.1 Infusion Pumps for Diabetes
2.4.2 Infusion Pumps for Chemotherapy
2.4.3 Infusion Pumps for Analgesia
2.4.4 Infusion Pumps for Enteral Feeding
2.4.5 Other Uses for Infusion Pumps
2.5 Advantages and Disadvantages of Infusion Pumps
3. Infusion Pumps: World Market, 2016-2027
3.1 World Medical Devices Market, 2016-2027
3.2 Infusion Pump Market Definition
3.3 World Infusion Pumps Market, 2016
3.4 World Infusion Pumps Market Forecast, 2016-2027
3.4.1 The Infusion Pumps Market Forecast, 2016-2021
3.4.2 The Infusion Pumps Market Forecast, 2022-2027
3.5 The Infusion Pumps Market: Insulin Pumps Are Market Leaders
3.6 How Will Segmental Market Shares Change to 2027?
3.7 World Infusion Pumps Market: Drivers and Restraints, 2016-2027
3.7.1 Ageing Population and Rising Incidences of Chronic Diseases
3.7.2 Advancement in Infusion Pump Technologies
3.7.3 A Shift towards Home Care
3.7.4 Safety Risk and Stringent Approval Process
4. Leading National Markets, 2016-2027
4.1 Regional Breakdown of World Infusion Pumps Market, 2016
4.2 Infusion Pumps National Market Forecast, 2016-2027
4.2.1 How Will National Market Shares Change to 2027?
4.3 US Infusion Pumps Market, 2016-2027
4.3.1 US Medical Device Regulations, 2016-2027
4.3.2 US Infusion Pumps Market Forecast, 2016-2027
4.4 EU Infusion Pumps Market 2016
4.4.1 EU Medical Device Approval and Regulations
4.4.2 The EU Approval and Regulation System
4.4.3 Changes in the New EU Medical Device Regulations
4.4.4 Post Marketing Surveillance in the EU
4.4.5 EU Infusion Pumps Market Forecast, 2016-2027
4.4.6 How Will EU Market Shares Change to 2027?
4.4.7 German Infusion Pumps Market Forecast, 2016-2027
4.4.8 French Infusion Pumps Market Forecast, 2016-2027
4.4.9 UK Infusion Pumps Market Forecast, 2016-2027
4.4.10 Italian Infusion Pumps Market Forecast, 2016-2027
4.4.11 Spanish Infusion Pumps Market Forecast, 2016-2027
4.5 Japanese Infusion Pumps Market, 2016
4.5.1 Japan: Improved Approval Process
4.5.2 Japanese Infusion Pumps Market Forecast, 2016-2027
4.6 Chinese Infusion Pumps Market, 2016
4.6.1 Chinese Infusion Pumps Market Forecast, 2016-2027
4.6.2 China’s 12th Five-Year-Plan (2010-2015)
4.6.3 New Policies Favouring Domestically-Made Medical Devices
4.7 Indian Infusion Pumps Market 2016
4.7.1 Indian Infusion Pumps Market Forecast, 2016-2027
4.8 Brazilian Infusion Pumps Market, 2016
4.8.1 Brazilian Infusion Pumps Market Forecast, 2016-2027
4.9 South Korean Infusion Pumps Market, 2016
4.9.1 South Korean Infusion Pumps Market Forecast, 2016-2027
4.10 Russian Infusion Pumps Market, 2016
4.10.1 Russian Infusion Pumps Market Forecast, 2016-2027
5. Insulin Pumps Submarket, 2016-2027
5.1 Introduction to Insulin Pumps
5.2 Insulin in Insulin Pumps
5.2.1 Bolus Infusion
5.2.2 Basal Infusion
5.3 Advantages and Disadvantages of Insulin Pumps
5.4 Human Insulin and Analogues
5.5 Insulin Infusion Pumps Submarket, 2016
5.6 Insulin Pumps Submarket Regional Breakdown, 2016
5.7 Insulin Pumps Submarket: Sales Forecast, 2016-2027
5.8 Insulin Pumps Submarket: Sales Forecast, 2016-2021
5.9 Insulin Pumps Submarket: Sales Forecast, 2022-2027
5.10 Leading Products in Insulin Pumps Submarket, 2016
5.10.1 MiniMed (Medtronic)
5.10.2 OmniPod (Insulet Corporation)
5.10.3 OneTouch Ping (Animas Corporation)
5.10.4 Accu-Chek Spirit (Disetronic, subsidiary of Roche)
5.10.5 t:Slim (Tandem Diabetes Care)
5.10.6 Animas Vibe (Animas Acquired by Johnson & Johnson)
5.10.7 DANA Diabecare IISG (SOOIL)
5.10.8 SpringZone (D. Medical Industries)
5.10.9 Cellnovo (Cellnovo)
5.10.10 V-Go (Valeritas)
5.11 Key Insulin Pumps Pipeline Products, 2016
5.11.1 Finesse Personal Insulin Patch (Johnson & Johnson)
5.11.2 SOLO MicroPump (Roche)
5.11.3 Artificial Pancreas (Juvenile Diabetes Research Foundation)
5.11.4 Freehand (MedSolve Technologies)
5.11.5 NanoPump (Debiotech)
5.11.6 PassPort (Altea Therapeutics)
5.11.7 NiliPatch (D. Medical Industries)
5.12 Insulin Pumps Submarket: Drivers and Restraints, 2016-2027
5.12.1 Increased Competition Drives Innovation
5.12.2 Collaborating to Address Unmet Needs
5.12.3 A Strong R&D Pipeline Will Drive the Market
5.12.4 Diabetes Globalisation: A Rapidly Increasing Incidence
5.13 Developed Economies: Increasing Adoption
5.14 Reimbursement of Insulin Pumps Will Give Long-Term Economic Benefits
5.15 More Expensive Technology Presents a Challenge When Entering Emerging Markets
5.16 Security Risks with Insulin Pumps
6. Enteral Feeding Pumps Submarket, 2016-2027
6.1 Introduction to Enteral Feeding Pumps
6.1.1 Clinical Settings That May Require Enteral Feeding
6.1.2 Advantages and Disadvantages of Enteral Feeding
6.2 Delivery of Enteral Feeding
6.2.1 Tube Placements Used in Enteral Feeding
6.2.2 Enteral Feeding at Home
6.2.3 Enteral Feeding Pumps Submarket, 2016
6.2.4 Enteral Feeding Pumps Submarket Regional Breakdown, 2016
6.3 Enteral Feeding Pumps Submarket: Sales Forecast, 2016-2027
6.3.1 Enteral Feeding Pumps Submarket: Sales Forecast, 2016-2021
6.3.2 Enteral Feeding Pumps Submarket: Sales Forecast, 2022-2027
6.4 Leading Products in Enteral Feeding Pump Submarket 2016
6.4.1 Compat DualFlo Enteral Feeding Pump (Acquired by Medline)
6.4.2 Sentinel Enteral Feeding Pump (ALCOR Scientific)
6.4.3 EnteraLite Infinity Enteral Feeding Pump (Zevex /Moog)
6.4.4 APPLIX Vision (Fresenius Kabi)
6.4.5 MiniFlo (Fresenius Kabi)
6.4.6 Nutricia FloCare Infinity Pump (Danone Nutricia)
6.4.7 Sapphire (Q Core Medical)
6.4.8 Kangaroo Joey Enteral Feeding Pump (Covidien)
6.4.9 Other Notable Enteral Feeding Pumps
6.5 Enteral Feeding Pumps Submarket: Drivers and Restraints, 2016-2027
6.5.1 Cost-Effective, Portable and Safer Products Will Drive Growth
6.5.2 Growing World Geriatric Population and Prevalence of Chronic Diseases
6.5.3 Increasing Demand for Homecare Solutions and Portability
6.5.4 Exit of Abbott in the US Enteral Feeding Market in 2015
6.5.5 Introduction of ISO’s Standards for Small-Bore Connectors
6.5.6 Replacement of Pumps and Sales of Disposable Feeding Sets Will Sustain Market Revenue
6.5.7 Highly Competitive Market with High Barriers to Entry
7. Other Infusion Pumps Submarket, 2016-2027
7.1 Other Infusion Pumps Submarket Definition
7.2 Other Infusion Pumps Submarket, 2016
7.3 Other Infusion Pumps Submarket: Sales Forecast, 2016-2027
7.4 Chemotherapy Pumps
7.5 Advantages and Disadvantages of Chemotherapy Pumps
7.6 Leading Drugs in the Oncology Therapeutics Market, 2016
7.7 The Chemotherapy Pumps Market, 2016
7.8 Leading Products in Chemotherapy Pumps Market, 2016
7.8.1 Infusor Infusion Pump (Baxter)
7.8.2 CODMAN 3000 (Johnson & Johnson)
7.8.3 Optima MS (Fresenius Kabi)
7.8.4 CADD Legacy-1 (Smiths Medical)
7.8.5 Other Notable Chemotherapy Pumps
7.9 Chemotherapy Pumps Market: Drivers and Restraints, 2016-2027
7.10 Patient Controlled Analgesia (PCA) Pumps
7.10.1 Clinical Settings Where PCA Pumps Are Used
7.10.2 How Does a PCA Pump Work?
7.10.3 Advantages and Disadvantages of PCA Pumps
7.11 Narcotic Drugs
7.12 Leading Products in the PCA Pumps Market 2016
7.12.1 LifeCare PCA 7.0 with Hospira MedNet Software (Hospira)
7.12.2 Alaris PCA (CareFusion)
7.12.3 Baxter PCA II (Baxter)
7.12.4 Curlin PainSmart IOD Pain Management System (B.Braun)
7.12.5 CADD-Solis Infusion Pump (Smiths Medical)
7.12.6 Other Notable PCA Pumps
7.13 PCA Pumps Market: Drivers and Restraints, 2016-2027
8. Competing Technology Analysis, 2016-2027
8.1 Drug Delivery Technologies
8.2 Types of Technologies for Drug Delivery
8.2.1 Sustained/Controlled Release Systems
8.2.2 Injection
8.2.3 Needle Free Injections
8.2.4 Pulmonary, Buccal and Nasal Delivery
8.2.5 Pills and Capsules
8.3 World Drug Delivery Technologies Market, 2016
8.4 Drug Delivery Technologies Market Regional Breakdown, 2016
8.5 World Drug Delivery Technologies Market Forecast, 2016-2027
8.6 Key Drug Delivery Pipeline Products, 2016
9. Qualitative Analysis of the Infusion Pumps Market, 2016-2027
9.1 SWOT Analysis of World Infusion Pumps Market, 2016-2027
9.2 Strengths
9.2.1 Highly Accurate Dosing at Regular Intervals
9.2.2 Improved Quality of Life and Less Hospital Visits
9.2.3 Used in a Wide Range of Clinical Settings
9.3 Weaknesses
9.3.1 Safety Concerns Will Call for Stricter Regulation
9.3.2 Discomfort May Discourage Potential Users
9.3.3 Expensive Technologies May Restrain the Market
9.4 Opportunities
9.4.1 Emerging Economies Are Growing
9.4.2 Patient Demographics
9.4.3 High Demand for Technological Advancements
9.4.4 Drugs Coming Off-Patent Will Help to Drive the Market
9.5 Threats
9.5.1 Poor Economic Conditions in Key Regions of the Market
9.5.2 Cost Effectiveness May Be Difficult to Prove
9.5.3 Regulatory Bodies Can Make Entry to Market Difficult
9.5.4 Technological Advances in Drug Delivery May Surpass Those in Infusion
9.6 Porter’s Five Forces Analysis of the Infusion Pumps Market
9.6.1 Competitive Market Leaders [High]
9.6.2 Threat of New Entrants [Medium]
9.6.3 Power of Suppliers [Medium]
9.6.4 Bargaining Power of Buyers [High]
9.6.5 Threat of Substitutes [Medium]
10. Conclusion
10.1 Infusion Pumps: A Growing Industry
10.2 Current Look at the World Infusion Pumps Market, 2016
10.3 The Global Infusion Pumps Market: Driven or Restrained?
Appendices
Associated Visiongain Reports
Visiongain Report Sales Order Form
About Visiongain
Report Evaluation Form
List of Figures
Figure 1.1 Top Five National Infusion Pumps Market by Revenue, 2016 & 2027
Figure 1.2 World Infusion Pumps Market Segmentation Overview, 2016
Figure 2.1 Positive Displacement Pump Mechanism
Figure 3.1 World Medical Devices Market Forecast: Revenue ($bn) 2016-2027
Figure 3.2 World Infusion Pumps Market Forecast: Revenue ($bn), 2016-2027
Figure 3.3 World Infusion Pumps Market Forecast: Revenues ($bn) by Segment, 2016-2027
Figure 3.4 World Infusion Pumps Market: Market Shares (%) by Segment, 2016
Figure 3.5 World Infusion Pumps Market: Market Shares (%) by Segment, 2021
Figure 3.6 World Infusion Pumps Market: Market Shares (%) by Segment, 2027
Figure 3.7 World Infusion Pumps Market: Drivers and Restraints, 2016-2027
Figure 4.1 World Infusion Pumps Market: Revenue ($bn) by Region, 2016
Figure 4.2 World Infusion Pumps Market: Market Shares (%) by Region, 2016
Figure 4.3 World Infusion Pumps Market Forecast: Comparison between Revenue ($bn) by Region, 2016, 2021, and 2027
Figure 4.4 World Infusion Pumps Market Forecast: CAGR (%) by Region in 2016-2021, 2022-2027, and 2016-2027
Figure 4.5 World Infusion Pumps Market: Market Shares (%) by Region, 2021
Figure 4.6 World Infusion Pumps Market: Market Shares (%) by Region, 2027
Figure 4.7 US 65+ Population Forecast: Size (m), 2016-2027
Figure 4.8 US Infusion Pumps Market Forecast: Revenues ($bn), 2016-2027
Figure 4.9 EU5 Infusion Pumps Market: Leading Countries by Revenue ($bn), 2016
Figure 4.10 EU5 Infusion Pumps Market: Leading Countries by Market Share (%), 2016
Figure 4.11 EU5 Infusion Pumps Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
Figure 4.12 EU5 Infusion Pumps Market Forecast: Revenues ($bn) by Leading Countries, 2016-2027
Figure 4.13 EU5 Infusion Pumps Market Forecast: CAGR (%) by Leading Countries in 2016-2021, 2022-2027 and 2016-2027
Figure 4.14 EU5 Infusion Pumps Market: EU Market Shares (%) by Leading Countries, 2021
Figure 4.15 EU5 Infusion Pumps Market: EU Market Shares (%) by Leading Countries, 2027
Figure 4.16 Germany Infusion Pumps Market Forecast: Revenues ($bn) 2016-2027
Figure 4.17 French Infusion Pumps Market Forecast: Revenues ($bn), 2016-2027
Figure 4.18 UK Infusion Pumps Market Forecast: Revenues ($bn), 2016-2027
Figure 4.19 Italian Infusion Pumps Market Forecast: Revenues ($bn), 2016-2027
Figure 4.20 Spanish Infusion Pumps Market Forecast: Revenues ($bn) and AGR (%), 2016-2027
Figure 4.21 Japanese Infusion Pumps Market Forecast: Revenues ($bn), 2016-2027
Figure 4.22 Chinese Infusion Pumps Market Forecast: Revenues ($bn) 2016-2027
Figure 4.23 China’s Historical Healthcare Expenditure ($bn), 2001-2010
Figure 4.24 Chinese Population: Aged 65 or Over (million) in 1950, 2010 and 2050
Figure 4.25 Indian Infusion Pumps Market Forecast: Revenues ($bn) and AGR (%), 2016-2027
Figure 4.26 Brazilian Infusion Pumps Market Forecast: Revenues ($bn), 2016-2027
Figure 4.27 South Korean Infusion Pumps Market Forecast: Revenues ($bn) 2016-2027
Figure 4.28 Russian Infusion Pumps Market Forecast: Revenues ($bn), 2016-2027
Figure 5.1 Insulin Analogues Submarket: Revenue ($bn) by Leading Products, 2016
Figure 5.2 Insulin Analogues Submarket: Leading Products by Market Shares (%), 2016
Figure 5.3 Insulin Pumps Submarket: Revenues ($bn) by Region, 2016
Figure 5.4 World Insulin Pumps Market: Market Shares (%) by Region, 2016
Figure 5.5 Insulin Pumps Submarket Forecast: Revenue ($bn) and AGR (%), 2016-2027
Figure 5.6 Insulin Pumps Submarket: Drivers and Restraints, 2016-2027
Figure 5.7 Diabetes Prevalence (%) in Leading National Markets, 2016
Figure 6.1 Conditions That Require The Use Of Enteral Feeding Pumps, 2016
Figure 6.2 Enteral Feeding Pumps Submarket: Revenues ($bn) by Region, 2016
Figure 6.3 World Enteral Feeding Pumps Market: Market Shares (%) by Region, 2016
Figure 6.4 Enteral Feeding Pumps Submarket: Drivers and Restraints, 2016-2027
Figure 7.1 Other Infusion Pumps Submarket Forecast: Revenue ($bn), 2016-2027
Figure 7.2 Top 10 Oncology Pharmaceuticals: Revenues ($bn), 2016
Figure 7.3 Top 10 Oncology Pharmaceuticals: Market Shares (%), 2016
Figure 7.4 Chemotherapy Pumps World Market: Drivers and Restraints, 2016-2027
Figure 7.5 Routes of PCA Administration
Figure 7.6 PCA Pumps World Market: Drivers and Restraints, 2016-2027
Figure 8.1 World Drug Delivery Technologies Market: Revenues ($bn) by Application, 2016
Figure 8.2 World Drug Delivery Technologies Market: Market Shares (%) by Application, 2016
Figure 8.3 World Drug Delivery Technologies Market: Revenues ($bn) by Country, 2016
Figure 8.4 World Drug Delivery Technologies Market: Market Shares (%) by Country, 2016
Figure 8.5 Global Drug Delivery Market Forecast: Revenue ($bn) , 2016-2027
Figure 9.1 Insulin Delivery Technologies: Average Annual Costs of Usage 2016 ($)
Figure 9.2 World Population Aged 65+ Forecast: Population (millions) and AGR (%), 2016-2027
Figure 9.3 Porter’s Five Forces Analysis of the Infusion Pumps Market, 2016-2027
Figure 11.1 Top Five National Infusion Pumps Market by Revenue ($bn), 2016 & 2027
Figure 11.2 Main Drivers and Restraints In The Global Infusion Pumps Market, 2016-2027
List of Tables
Table 1.1 Infusion Pumps: Leading National Markets Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2027
Table 2.1 Four Types of Infusion
Table 2.2 Advantages and Disadvantages of syringe pumps
Table 2.3 Advantages and Disadvantages of Insulin Pumps
Table 2.4 Advantages and Disadvantages of Infusion Pumps
Table 3.1 World Medical Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2021
Table 3.1.1 World Medical Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2022-2027
Table 3.2 World Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2027
Table 3.2.1 World Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
Table 3.3 Market Shares (%) of Infusion Pumps by Market Segment 2016-2021
Table 3.3.1 Market Shares (%) of Infusion Pumps by Market Segment 2022-2027
Table 3.4 Percentage of the Population Over 65 Years of Age, 2016-2027
Table 4.1 Global Infusion Pumps Market: Revenue ($bn) and Market Shares (%) by Region, 2016
Table 4.2 World Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%) by Region, 2016-2027
Table 4.2.1 World Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%) by Region, 2016-2027
Table 4.3 World Infusion Pumps Market Forecast: CAGR (%) by Region in 2016-2021, 2022-2027 and 2016-2027
Table 4.4 Market Shares (%) of Infusion Pumps Market by Region, in 2016, 2021, and 2027
Table 4.4.1Classification of Medical Devices in the United States
Table 4.5 US Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2021
Table 4.5.1 US Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
Table 4.6 EU5 Infusion Pumps Market: Revenues ($bn) and EU Market Shares (%) by Leading Countries, 2016-2021
Table 4.6.1 EU5 Infusion Pumps Market: Revenues ($bn) and EU Market Shares (%) by Leading Countries, 2022-2027
Table 4.7 EU5 Infusion Pumps Market Forecast: Revenues ($bn), AGR (%), Market Share (%) and CAGR (%), 2016-2027
Table 4.8 EU5 Infusion Pumps Market Forecast: CAGR (%) by Leading Countries in 2016-2021, 2022-2027 and 2016-2027
Table 4.9 EU5 Market Shares (%) of the European Infusion Pumps Market by Leading Countries 2016, 2021, and 2027
Table 4.10 Germany Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2021
Table 4.10.1 Germany Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
Table 4.11 French Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2021
Table 4.11.1 French Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
Table 4.12 UK Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2021
Table 4.12.1 UK Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
Table 4.13 Italian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2021
Table 4.13.1 Italian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
Table 4.14 Spanish Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2021
Table 4.14.1 Spanish Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
Table 4.15 Japanese Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2021
Table 4.15.1 Japanese Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
Table 4.16 Chinese Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2021
Table 4.16.1 Chinese Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
Table 4.17 Indian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2021
Table 4.17.1 Indian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
Table 4.18 Brazilian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2021
Table 4.18.1 Brazilian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
Table 4.19 South Korean Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2021
Table 4.19.1 South Korean Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
Table 4.20 Russian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2021
Table 4.20.1 Russian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
Table 5.1 Control of Insulin Delivery (Infusion Types and Methods)
Table 5.2 Advantages and Disadvantages of Insulin Pumps
Table 5.3 Insulin Analogues Submarket: Leading Products by Revenue ($bn) and Market Shares (%), 2016
Table 5.4 Insulin Pumps Submarket: Revenue ($bn) and Market Shares (%) by Region, 2016
Table 5.5 Insulin Pumps Submarket Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2021
Table 5.5.1 Insulin Pumps Submarket Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
Table 5.6 Leading Products in the Insulin Pumps Submarket, 2016
Table 5.7 Key Pipeline Products for Insulin Pumps Submarket, 2016
Table 5.8 Diabetes Prevalence (m) in Leading National Markets, 2016
Table 6.1 Advantages and Disadvantages of Enteral Feeding, 2016
Table 6.2 Types of Tubes Used in Enteral Feeding, 2016
Table 6.3 Enteral Feeding Pumps Submarket: Revenues ($bn) and Market Shares (%) by Region, 2016
Table 6.4 Enteral Feeding Pumps Submarket Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2021
Table 6.4.1 Enteral Feeding Pumps Submarket Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
Table 6.5 Leading Products in the Enteral Feeding Pumps Submarket, 2016
Table 6.6 Other Products in the Enteral Feeding Pumps Submarket, 2016
Table 7.1 Other Infusion Pumps Submarket Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2021
Table 7.1.1 Other Infusion Pumps Submarket Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
Table 7.2 Advantages and Disadvantages of Chemotherapy Pumps
Table 7.3 Oncology Pharmaceuticals: Revenue ($bn) and Market Shares (%), 2016
Table 7.4 Top 10 Oncology Pharmaceuticals: Key Facts
Table 7.5 Leading Products in the Chemotherapy Pump Market, 2016
Table 7.6 Advantages and Disadvantages of PCA Pumps
Table 7.7 Leading Products in the PCA Pumps Market, 2016
Table 7.8 Other Noticeable PCA Pumps
Table 8.1 World Drug Delivery Technologies Market: Revenue ($bn) and Market Shares (%) by Application, 2016
Table 8.2 World Drug Delivery Technologies Market: Revenue ($bn) and Market Shares (%) by Country, 2016
Table 8.3 World Drug Delivery Technologies Market Forecast: Revenues ($bn), AGR (%) and CAGR (%) by Application, 2016-2021
Table 8.3.1 World Drug Delivery Technologies Market Forecast: Revenues ($bn), AGR (%) and CAGR (%) by Application, 2022-2027
Table 8.4 Key Pipeline Products for Oral Delivery, 2016
Table 8.5 Key Pipeline Products for Transdermal, Transmucosal, and Implantable Delivery, 2016
Table 8.6 Key Pipeline Products for Inhaled and Injectable Delivery, 2016
Table 9.1 SWOT Analysis of World Infusion Pumps Market 2016-2027
Table 9.2 Average Initial Costs Associated With Insulin Pump Use 2016 ($)
Table 9.3 Insulin Delivery Technologies: Average Annual Costs of Usage 2016 ($)
Table 9.4 Infusion Pumps and Related Products Recall in the US, 2007-2016
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
